Microcirculatory alterations in ischemia–reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition
Open Access
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 9 (4) , S33-S37
- https://doi.org/10.1186/cc3758
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Coagulation inhibitor replacement during sepsis: Useless?Critical Care Medicine, 2000
- Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complicationsCritical Care Medicine, 2000
- Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liverHepatology, 1997
- The microcirculation during endotoxemiaCardiovascular Research, 1996
- Microvascular perfusion is impaired in a rat model of normotensive sepsis.Journal of Clinical Investigation, 1994
- Modulators of coagulation. A critical appraisal of their role in sepsisArchives of internal medicine (1960), 1992
- Role of intercellular adhesion molecule-1 in the inflammatory responseKidney International, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityPublished by Elsevier ,1991
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987